Response to Neisseria gonorrhoeae by Cervicovaginal Epithelial Cells Occurs in the Absence of Toll-Like Receptor 4-Mediated Signaling1

Toll-like receptors (TLRs) have recently been identified as fundamental components of the innate immune response to bacterial pathogens. We investigated the role of TLR signaling in immune defense of the mucosal epithelial cells of the lower female genital tract. This site provides first line defense against microbial pathogens while remaining tolerant to a complex biosystem of resident microbiota. Epithelial cells derived from normal human vagina, ectocervix, and endocervix expressed mRNA for TLR1, -2, -3, -5, and -6. However, they failed to express TLR4 as well as MD2, two essential components of the receptor complex for LPS in phagocytes and endothelial cells. Consistent with this, endocervical epithelial cells were unresponsive to protein-free preparations of lipooligosaccharide from Neisseria gonorrhoeae and LPS from Escherichia coli. However, they were capable of responding to whole Gram-negative bacteria and bacterial lysates, as demonstrated by NF-κB activation and proinflammatory cytokine production. The presence of soluble CD14, a high-affinity receptor for LPS and other bacterial ligands, enhanced the sensitivity of genital tract epithelial cells to both low and high concentrations of bacteria, suggesting that soluble CD14 can act as a coreceptor for non-TLR4 ligands. These data demonstrate that the response to N. gonorrhoeae and other Gram-negative bacteria at the mucosal surface of the female genital tract occurs in the absence of endotoxin recognition and TLR4-mediated signaling.

[1]  T. Ogawa,et al.  Bacterial Fimbriae and Their Peptides Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2 , 2001, Infection and Immunity.

[2]  F. C. Gibson,et al.  Distinct Proinflammatory Host Responses to Neisseria gonorrhoeae Infection in Immortalized Human Cervical and Vaginal Epithelial Cells , 2001, Infection and Immunity.

[3]  D. Anderson,et al.  The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. , 2001, The Journal of infectious diseases.

[4]  M. Abreu,et al.  Decreased Expression of Toll-Like Receptor-4 and MD-2 Correlates with Intestinal Epithelial Cell Protection Against Dysregulated Proinflammatory Gene Expression in Response to Bacterial Lipopolysaccharide1 , 2001, The Journal of Immunology.

[5]  M. Arditi,et al.  Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.

[6]  D. Schwartz,et al.  Molecular Genetic Analysis of an Endotoxin Nonresponder Mutant Cell Line A Point Mutation in a Conserved Region of Md-2 Abolishes Endotoxin-Induced Signaling , 2001 .

[7]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[8]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[9]  D. Golenbock,et al.  Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2 , 2001, Infection and Immunity.

[10]  J. Keane,et al.  Differential Effects of a Toll-Like Receptor Antagonist on Mycobacterium tuberculosis-Induced Macrophage Responses1 , 2001, The Journal of Immunology.

[11]  I. Gipson,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle* , 2022 .

[12]  A. Aderem,et al.  Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin1 , 2001, The Journal of Immunology.

[13]  S. Dower,et al.  Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells1 , 2001, The Journal of Immunology.

[14]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[15]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Podolsky,et al.  Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease , 2000, Infection and Immunity.

[17]  S. Cox,et al.  Infection and preterm labor. , 2000, Clinical obstetrics and gynecology.

[18]  S. Randell,et al.  CD14-dependent Lipopolysaccharide-induced β-Defensin-2 Expression in Human Tracheobronchial Epithelium* , 2000, The Journal of Biological Chemistry.

[19]  S. Vogel,et al.  Cutting Edge: Repurification of Lipopolysaccharide Eliminates Signaling Through Both Human and Murine Toll-Like Receptor 21 , 2000, The Journal of Immunology.

[20]  C. Cho,et al.  Regulation of interleukin 6 production in a human gastric epithelial cell line MKN-28. , 2000, Cytokine.

[21]  Moilanen,et al.  Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor‐κB‐dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin , 2000 .

[22]  S. Krisanaprakornkit,et al.  Inducible Expression of Human β-Defensin 2 byFusobacterium nucleatum in Oral Epithelial Cells: Multiple Signaling Pathways and Role of Commensal Bacteria in Innate Immunity and the Epithelial Barrier , 2000, Infection and Immunity.

[23]  M. Arditi,et al.  Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells , 2000, The Journal of Biological Chemistry.

[24]  K. Takeda,et al.  Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.

[25]  V. Uitto,et al.  Epithelial cell response to challenge of bacterial lipoteichoic acids and lipopolysaccharides in vitro. , 2000, Journal of medical microbiology.

[26]  D. Golenbock,et al.  Human Toll-Like Receptor 2 Mediates Monocyte Activation by Listeria monocytogenes, But Not by Group B Streptococci or Lipopolysaccharide1 , 2000, The Journal of Immunology.

[27]  B. Monks,et al.  Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. , 2000, The Journal of clinical investigation.

[28]  D. Podolsky,et al.  Lipopolysaccharide Activates Distinct Signaling Pathways in Intestinal Epithelial Cell Lines Expressing Toll-Like Receptors1 , 2000, The Journal of Immunology.

[29]  L. Kelly,et al.  Optimization of the Weck-Cel Collection Method for Quantitation of Cytokines in Mucosal Secretions , 2000, Clinical Diagnostic Laboratory Immunology.

[30]  G. Diamond,et al.  Transcriptional Regulation of β-Defensin Gene Expression in Tracheal Epithelial Cells , 2000, Infection and Immunity.

[31]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[32]  D. Golenbock,et al.  Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.

[33]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[34]  J. Radolf,et al.  Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. , 1999, Journal of immunology.

[35]  R. Medzhitov,et al.  Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. , 1999, The Journal of clinical investigation.

[36]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[37]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[38]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[39]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[40]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[41]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[42]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[43]  D. Anderson,et al.  Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. , 1999, Biology of reproduction.

[44]  S. Roman-Roman,et al.  A Mycoplasma fermentans-derived Synthetic Lipopeptide Induces AP-1 and NF-κB Activity and Cytokine Secretion in Macrophages via the Activation of Mitogen-activated Protein Kinase Pathways* , 1998, The Journal of Biological Chemistry.

[45]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[46]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[47]  S. Frøland,et al.  Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. , 1998, Blood.

[48]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[49]  S. Saccani,et al.  The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6) , 1998, The Journal of experimental medicine.

[50]  R. M. Wooten,et al.  The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. , 1998, Journal of immunology.

[51]  S. Mok,et al.  Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. , 1998, The American journal of pathology.

[52]  R. Tapping,et al.  Binding of Bacterial Peptidoglycan to CD14* , 1998, The Journal of Biological Chemistry.

[53]  D. Anderson,et al.  Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. , 1998, AIDS research and human retroviruses.

[54]  J. Mestecky,et al.  Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. , 1998, AIDS research and human retroviruses.

[55]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Z. Cao,et al.  MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. , 1997, Immunity.

[57]  D. Anderson,et al.  Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. , 1997, Biology of reproduction.

[58]  P. Ward,et al.  Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. , 1997, American journal of respiratory cell and molecular biology.

[59]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[60]  I. Gipson,et al.  Mucin genes expressed by human female reproductive tract epithelia. , 1997, Biology of reproduction.

[61]  G. Hardiman,et al.  Molecular characterization and modular analysis of human MyD88. , 1996, Oncogene.

[62]  K. Racké,et al.  Effects of bacterial lipopolysaccharides (LPS) and tumour necrosis factor-alpha (TNF alpha) on rat tracheal epithelial cells in culture: morphology, proliferation and induction of nitric oxide (NO) synthase. , 1996, Pulmonary pharmacology.

[63]  T. Bestebroer,et al.  Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains , 1996, Applied and environmental microbiology.

[64]  S. Wright,et al.  Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses , 1995, The Journal of experimental medicine.

[65]  H. Flad,et al.  Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures , 1994, Infection and immunity.

[66]  R. Thieringer,et al.  CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. , 1994, The Journal of biological chemistry.

[67]  A. Tomasz,et al.  CD14 is a pattern recognition receptor. , 1994, Immunity.

[68]  C. Manthey,et al.  Elimination of trace endotoxin protein from rough chemotype LPS , 1994 .

[69]  M. Wurfel,et al.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 , 1994, The Journal of experimental medicine.

[70]  M. Kagnoff,et al.  Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. , 1993, Gastroenterology.

[71]  N. Liabakk,et al.  Immunology: High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasma , 1993 .

[72]  J. Silver,et al.  Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. , 1993, Journal of immunology.

[73]  R. Ulevitch,et al.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[75]  B. Finlay,et al.  Soluble CD14 participates in the response of cells to lipopolysaccharide , 1992, The Journal of experimental medicine.

[76]  C. Elson,et al.  Cells and cytokines in mucosal immunity and inflammation. , 1992, Gastroenterology clinics of North America.

[77]  M. Press,et al.  Estrogen receptor localization in the female genital tract. , 1986, The American journal of pathology.

[78]  G. Seymour,et al.  Modulation of HLA-DR antigens in the gingival epithelium in vitro by heat-killed Fusobacterium nucleatum and E. coli lipopolysaccharide. , 1985, Journal of oral pathology.

[79]  D. Sussman,et al.  Short-term, high-efficiency expression of transfected DNA , 1984, Molecular and cellular biology.

[80]  M. Peeters,et al.  Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali. , 1998, AIDS research and human retroviruses.

[81]  E. Kopp,et al.  NF-kappa B and rel proteins in innate immunity. , 1995, Advances in immunology.

[82]  K. Anderson,et al.  Signaling pathways that establish the dorsal-ventral pattern of the Drosophila embryo. , 1995, Annual review of genetics.

[83]  M. Kagnoff,et al.  Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. , 1994, Immunology.

[84]  N. Liabakk,et al.  High concentrations of the soluble p55 tumour necrosis factor receptor in human seminal plasma. , 1993, Human reproduction.

[85]  C. Raetz,et al.  Biochemistry of endotoxins. , 1990, Annual review of biochemistry.